Despite being a common clinical symptom, fever often presents a diagnostic challenge due to its myriad potential causes. This article aims to provide a comprehensive guide to approaching fever in clinical practice, focusing on key diagnostic considerations and strategies.
Understanding the pathophysiology of fever is crucial in its diagnosis. Fever is typically a manifestation of the body's immune response to infection, inflammation, or malignancy. It results from the action of pyrogens triggering the hypothalamus to raise the body's "set point" temperature.
A systematic and thorough clinical assessment is the cornerstone of diagnosing the cause of fever. This includes a detailed history taking, focusing on the onset, duration, pattern of fever, associated symptoms, travel history, and exposure to infectious agents. Physical examination should be comprehensive, with attention to signs that may point to a specific etiology.
Appropriate laboratory and imaging studies are essential in the diagnostic process. Initial tests may include complete blood count, blood cultures, urinalysis, and chest X-ray. The choice of further investigations should be guided by the clinical suspicion based on history and physical examination findings.
While the diagnostic workup is ongoing, empirical therapy may be initiated based on the likely diagnosis. However, regular reassessment is crucial, as the clinical picture may evolve over time, necessitating a change in the diagnostic approach or therapeutic strategy.
Deciphering the cause of fever requires a systematic approach, combining a thorough history and physical examination with appropriate investigations. Regular reassessment is key, as the clinical picture may evolve. By adopting this structured approach, clinicians can enhance their diagnostic accuracy, leading to improved patient outcomes.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation